Navigation Links
Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
Date:12/3/2007

Results Show Statistically Significant Indications of PS433540's Potential

in Treating Hypertension

PRINCETON, N.J., Dec. 3 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today additional results from the Company's Phase 1 multiple ascending dose (MAD) study of its lead internal product candidate, PS433540 (DARA). Data demonstrated that PS433540 produced statistically significant, dose dependent increases in plasma-renin activity levels, as well as reductions in systolic and diastolic blood pressure. These findings are in addition to previously reported initial results from the MAD trial that showed all doses of PS433540 to be safe and well-tolerated. This MAD study was designed to evaluate the 14-day safety and tolerability of 50, 100, 250, 500 and 1,000 mg doses of PS433540 in healthy volunteers.

The trial's positive plasma-renin activity and blood pressure findings provide preliminary insight into the potential of PS433540 to treat hypertension. Study investigators witnessed a dose dependent increase in plasma-renin activity levels for PS433540, which was more pronounced at Day 15 than at Day 1. This observed increase in plasma-renin activity is indicative of PS433540's ability to block the angiotensin receptor, a key target in efforts to lower and control blood pressure in hypertensive patients. Furthermore, associated with the increase in plasma-renin activity levels was a decrease in both diastolic and systolic blood pressure for PS433540 of up to 15 mmHg.

"While safety and tolerability of PS433540 across a broad range of doses up to 1,000 mg are the most important results of the MAD study, we are especially pleased to see, that even in healthy normotensive volunteers, signs of the compound's potential therapeutic activity are clearly discernable. Although preliminary, these results support the potential uti
'/>"/>

SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
3. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
4. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
5. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
6. Pharmacopeia Announces Third Quarter 2007 Financial Results
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , WHITEHOUSE STATION, N.J., Dec. 1 /PRN...that the U.S. Food and Drug Administration (FDA) h...um bicarbonate 1100 mg capsules), for over-the-cou... will be marketed over-the-counter by Schering-Plo...care division of Merck & Co., Inc. Schering-Pl...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 ...rch report is available in its catalogue: ,, T...sts to 2015, Competitive Benchmarking, Product Pip...linker.com/p0166817/The-Future-of-Oncology-Therape...marking-Product-Pipeline-and-Deals-Analysis.html ...
(Date:12/1/2009)..., , NEWNAN, Ga., Dec. 1 /PRNewswire/...ialty surface treatments for medical devices and o...nt and Chief Executive Officer, Thomas A. Gordy, w...ade at the Innovations in Cardiovascular Intervent...ve the era of petty self-interest behind and focus...
Breaking Medicine Technology:FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices 2Dr Susan Blumenthal Meridian International Centers Global Health Chair Named Health Leader of the Year 49759 1Dr Susan Blumenthal Meridian International Centers Global Health Chair Named Health Leader of the Year 49759 2Dr Susan Blumenthal Meridian International Centers Global Health Chair Named Health Leader of the Year 49759 3Marking anorexia with a brain protein 49756 1Medical Study Establishes First Ever Long Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement 49755 1
...ta on Newly-Approved Cimzia(R) Presented at Digest...nounced today that data,presented at Digestive Dis...cacy and safety of Cimzia(R) (certolizumab pegol) ... to severe Crohn,s disease. Data also showed,conti...and the remission,rate remained stable in many of ...
... Clinical trial data for Perforomist(TM) (Formoter... at International ATS Conference --, NAPA, Calif....l Conference of the American Thoracic Society (ATS...omist(TM) Inhalation Solution,(formoterol fumarate...tion,and Spiriva(R) (tiotropium; TIO) is significa...
Other Medicine Technology:Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 2Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 3Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 4Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 5Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 6Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 7Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 8Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 2Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 3Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 4Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 5Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 6
(Date:12/1/2009)..., Dec. 1 Reportlinker.com announce...n its catalogue: ,, Peptic Ulcer Testing - A W....reportlinker.com/p0164350/Peptic-Ulcer-Testing---...he prevalence of peptic ulcers in developing, and ...ped countries. The bacteria, helicobacter pylori (...
(Date:12/1/2009)...preterm births more likely, British study finds ,...egnant women who are poor are more likely to deliv...ven though both groups typically receive equal car...of Leicester research team said their findings sho...ween economic status and preterm birth. , For t...
(Date:12/1/2009)...S, Dec. 1 The American ...igh School Student Symposium at the New Orleans Ma...The symposium, which encourages an interest in hem...arch, is held in conjunction with the Society,s 51...he opportunity to explore research on sickle cell ...
(Date:12/1/2009)..., Dec. 1 On December 31...8 federal prisoners were HIV positive or had confi...in the Office of Justice Programs, U.S. Department...estimated 5,672 inmates in state and federal priso... 2007, about 43 per 10,000 prison inmates were est...
(Date:12/1/2009)...uld benefit from liver surgery after chemo, study ...ews) -- A CT scan of liver tumors caused by the sp... survival after chemotherapy, researchers report. ...motherapy has been shown to improve survival in pa...oduce better results in patients having surgery to...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Peptic Ulcer Testing - A World Market Intelligence Report 2Health News:Reportlinker Adds Peptic Ulcer Testing - A World Market Intelligence Report 3Health News:More Preemies Born Among the Poor 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2
...ugh what was once,Hurricane Gustav has weakened to...es all evacuees to stay away from affected areas u...w people are eager to go home, especially if they ...re,still unsafe in many places." If authorities ha...
...tion and Entertainment to State,s Largest Hospice ...LS, S.D., Sept. 2 LodgeNet,Healthcare, a division...T ),today announced that it has expanded into Hawa...ncis Hospice,established in 1978, is the oldest an...
...ver, Madonna," read a recent,San Francisco Chronic...t -,Music for the Soul debuted at #9 on the Billbo... of Pop and above Grammy Best New Artist of the,Ye...s #1 on the Billboard Classical Chart in the US, a...
...ce to prescribe antidepressants, study suggests , ...cides among U.S. children appear to be on the rise...n part, to fewer teens being prescribed antidepres... suicides continued during 2005. , Looking at suic...
...th University Massey Cancer Center recently opened...e II clinical study for certain sub-types of non-H...rch from VCU Massey Cancer Center as well as other... with diffuse large B-cell lymphoma, or mantle cel...
...olina at Chapel Hill researchers have demonstrated...ing, the need for intravenous fluids and hospital ... , Gastroenteritis is an infection, often caused ...onths. , "Children under the age of 5 years gener...
Other Medicine News:Health News:Red Cross Advises Evacuees to Stay Put Until Conditions Are Safe 2Health News:LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice 2Health News:LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice 3Health News:Youth Suicides Continue to Rise in U.S. 2Health News:Youth Suicides Continue to Rise in U.S. 3Health News:VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients 2Health News:Ondansetron reduces vomiting, hospital admissions in children with gastroenteritis 2
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: